期刊文献+

VISXStarS3准分子激光原位角膜磨镶术治疗中高度散光

Laser in situ keratomileusis for moderate and high astigmatism with VISX Star S3 excimer laser
原文传递
导出
摘要 目的观察VISX StarS3准分子激光原位角膜磨镶术治疗中高度散光的有效性、可预测性及安全性。方法采用回顾性的研究方法对25例36只眼首次接受VISX StarS3准分子激光原位角膜磨镶术的患者进行分析,入选患者散光均在2.0D以上且无角膜瓣并发症,术后随访至少6个月以上,观察术后裸眼视力、最佳眼镜矫正视力、残余散光度、散光的向量改变以及术后眩光发生情况。结果术前柱镜度平均(-2.65±0.70)D(-2.0—4.25D),平均球镜度(-6.28±3.05)D,范围+0.5~13.25D;术后83.3%视力在1.0以上,97.2%视力在0.5以上;16.7%最好矫正视力下降1行,没有出现最佳矫正视力下降超过1行的情况。术后平均残余散光度(0.46±0.44)D(0~1.25D),58.3%残余散光在±0.5D以内,94.4%残余散光在±1.0D以内,平均矫正指数为(0.98±0.18),平均失误角(3.30±3.8)度。25例中,6例患者术后至少有1只眼出现持续的夜间视力障碍或眩光。结论VISX StarS3准分子激光原位角膜磨镶术治疗中高度散光有良好的有效性、可预测性及安全性,但仍有相当比例的患者发生夜间眩光。 Objective To investigate the efficacy,predictability, and safety of laser in situ keratomileusis (LASIK) to correct moderate and high astigmatism with VISX Star S3. Methods We retrospectively studied 36 eyes of 25 patients who received primary LASIK using VISX Star S3 excimer laser, and the astigmatism of included eyes was at lest -2.00 diopters (D)and without flap complication. Follow-up was at least 6 months.Primary outcome measures included uncorrected visual acuity(UCVA), best spectacle-corrected visual acuity(BSCVA ), manifest refraction, an assessment of astigmatic correction through vector analysis, and the incidence of night glare.Results Preoperatively,the mean spherical component of refraction was (-6.28± 3.05 )D ( range, +0.5 to - 13.25D ), the mean refractive cylinder was ( -2.65 ± 0.70 )D (range, -2.0 to -4.25D ). Postoperatively, 97.2% had an uncorrected visual acuity of 0.5 or greater, whereas 83.3 % demonstrated an uncorrected visual acuity of 1.0 or greater. 16.7% of eyes lost 1 line of best spectacle-corrected visual acuity, and no eyes lost greater than 1 line of BSCVA. The mean refractive cylinder was (0.46± 0.44)D (range,0 to 1.25 D) with 58.3% ± 0.50 D and 94.4% ±1.00 D of intended. Vector analysis showed that mean correction index (CI) was 0.98± 0.18 with a mean angle of error of 3.30± 3.8 degrees. 6/25 of patients suffered a lasted night glare at least one eye. Conclusins LASIK with the VISX Star S3 excimer laser is effective,reasonably predictable, and safe for correction of moderate and high astigmatism, however, night glare of complains were not seldom.
出处 《中国实用眼科杂志》 CSCD 北大核心 2008年第9期918-920,共3页 Chinese Journal of Practical Ophthalmology
关键词 散光 角膜屈光手术 治疗结果 Astigmatism Refractive corneal surgery Eximer laser.
  • 引文网络
  • 相关文献

参考文献8

  • 1王铮,陈家祺,杨斌.准分子激光角膜切削术治疗近视散光的临床分析[J].中华眼科杂志,1997,33(2):132-135. 被引量:48
  • 2Haw WW,Manche EE.Photorefractive keratectomy for compound myopia astigmatism, Am J of Ophthalm, 2000,130:12-9.
  • 3Sugar A,Rapuano,CJ,Culbertson WW,et al.Laser in situ keratomileusis for myopia and astigmatism: safety and efficacy: a report by the American Academy of Ophthalmology. Ophthalmology, 2002, 109:175-87.
  • 4Alpins NA, FRACO, FRCOphth, et al. Practical astigmatism analysis for refractive outcomes for cataract and refractive surgery. Surv Ophthalmol, 2004,49 : 109-22.
  • 5McDonald MB, Cart JD,Frantz JM,et al.Laser in situ keratomileusis for myopia up to -11 diopters with up to -5 diopters of astigmatism with the summit autonomous LADARVision excimer laser system. Ophthalmology,2001,108: 309-16.
  • 6Yang C N,P .Shen E, Hu F R. Laser in situ kcratomileusis for the correction of myopic and astigmatism. J Cataract Refract Surg, 2001, 27:1952-60
  • 7Rashad KM. Laser in situ keratomileusis for myopia astigmatism.J Refract Surg. 1999,15: 653-60.
  • 8Bragheeth MA, Dua HS. Effect of refractive and topographic astigmatic axis on LASIK correction of myopic astigmatism. J Refract Surg. 2005,21 : 269-75.

共引文献47

;
使用帮助 返回顶部